These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8904143)

  • 1. Pseudomonas spp. and antibiotics in exacerbation of chronic obstructive pulmonary disease (COPD).
    Beghi G; Pasargiklian I; Mascheroni E; Boilini G; Scarazatti E; Lusco G
    J Chemother; 1995 Nov; 7 Suppl 4():163-4. PubMed ID: 8904143
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of new antibiotics in the treatment of Pseudomonas infections. I. In vitro tests].
    Pérez Ureña MT; Iriarte MT; Fernández P
    Rev Clin Esp; 1969 May; 113(3):235-40. PubMed ID: 5348710
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of infection in acute exacerbations of chronic obstructive pulmonary disease.
    Hillberg RE
    Am J Manag Care; 2000 May; 6(8 Suppl):S427-36. PubMed ID: 10977482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudomonas pyocyanea: in-vitro sensitivity to antibiotics].
    Cucchiara E
    G Mal Infett Parassit; 1971 Nov; 23(11):1045-7. PubMed ID: 5150979
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pulmonary Pseudomonas infections].
    Yu GH; Yuan JP; Zhong NS
    Zhonghua Nei Ke Za Zhi; 1990 Feb; 29(2):94-7, 126. PubMed ID: 2209236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Etest to assess synergy of antibiotic combinations against clinical isolates of Pseudomonas spp.
    Fodor E; Hajdú E; Nagy E
    Int J Antimicrob Agents; 2005 Feb; 25(2):183-4. PubMed ID: 15664494
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro antibacterial activity of aminoglycoside antibiotics against Pseudomonas strains.
    Panse MV; Nair KR
    Hindustan Antibiot Bull; 1981; 23():30-2. PubMed ID: 7309552
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic obstructive respiratory tract diseases: standards and trends of antibiotic therapy].
    Feist H; Armbruster C; Kapfhammer G; Vetter N; Drlicek M; Hackl H
    Prax Klin Pneumol; 1988 Jul; 42(7):529-32. PubMed ID: 3186652
    [No Abstract]   [Full Text] [Related]  

  • 9. [The relationship between different serological types of Pseudomonas aeruginosa strain in lower respiratory tract and its clinical significance].
    He G; Li H; Xu H
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):584-7. PubMed ID: 11477871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease.
    Martínez-Solano L; Macia MD; Fajardo A; Oliver A; Martinez JL
    Clin Infect Dis; 2008 Dec; 47(12):1526-33. PubMed ID: 18990062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug susceptibility of Pseudomonas bacilli in otorhinolaryngology].
    Iwasawa T
    Jibiinkoka; 1967 Nov; 39(11):1251-9. PubMed ID: 5627797
    [No Abstract]   [Full Text] [Related]  

  • 12. Aerosol antibiotics: considerations in pharmacological and clinical evaluation.
    Dudley MN; Loutit J; Griffith DC
    Curr Opin Biotechnol; 2008 Dec; 19(6):637-43. PubMed ID: 19036576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Best evidence topic report. Antibiotics in acute exacerbations of chronic obstructive pulmonary disease.
    Murphy R; McKechnie M; Dunning J
    Emerg Med J; 2004 Mar; 21(2):200-3. PubMed ID: 14988351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease.
    Murphy TF
    Curr Opin Pulm Med; 2009 Mar; 15(2):138-42. PubMed ID: 19532029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic obstructive pulmonary disease.
    Sethi S; Murphy TF
    N Engl J Med; 2000 Dec; 343(26):1969-70; author reply 1970-1. PubMed ID: 11186675
    [No Abstract]   [Full Text] [Related]  

  • 16. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
    Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
    Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the incidence of Pseudomonas in gangrenous lesions and its sensitivity to antibiotics and to chemoterapics.
    Brenciaglia MI; Cipriani P; Dainelli B; Mancini C
    Antibiotica; 1977 Mar; 14(1):47-57. PubMed ID: 879717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease].
    Cavassini M; Calandra T; Bridevaux PO
    Rev Med Suisse; 2007 Apr; 3(106):939-42. PubMed ID: 17575969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibiotic therapy of infections caused by Proteus and Pseudomonas pyocyanea].
    Chernomordik AB
    Klin Med (Mosk); 1972 Nov; 50(11):106-9. PubMed ID: 4666690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.